Track the latest insights on carnitine price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the carnitine prices in the USA reached 25150 USD/MT in September. Prices moved upward as demand from dietary supplements, pharmaceuticals, and functional nutrition products increased. Higher consumption of health and wellness products supported buying interest. Manufacturers secured material to support formulation requirements, while controlled supply availability influenced procurement planning.
During the third quarter of 2025, the carnitine prices in China reached 22500 USD/MT in September. Prices increased due to firm demand from nutraceutical manufacturing and export-oriented supplement production. Improved downstream order volumes supported consumption. Producers maintained structured output levels, while buyers aligned procurement with confirmed manufacturing schedules.
During the third quarter of 2025, the carnitine prices in Germany reached 32400 USD/MT in September. Prices rose as pharmaceutical and medical nutrition demand strengthened. Increased use of carnitine in therapeutic formulations supported consumption. Buyers emphasized quality compliance and regulatory standards, influencing sourcing decisions and procurement timing.
During the third quarter of 2025, the carnitine prices in India reached 20500 USD/MT in September. Prices moved upward amid rising demand from dietary supplement manufacturers and pharmaceutical producers. Expansion in domestic nutraceutical consumption supported offtake. Buyers secured material to support production runs, while import availability influenced sourcing strategies.
During the third quarter of 2025, the carnitine prices in the United Kingdom reached 28800 USD/MT in September. Prices increased as demand from sports nutrition, clinical nutrition, and pharmaceutical applications strengthened. Higher usage in specialty formulations supported procurement activity. Buyers focused on ensuring consistent supply for regulated end-use applications.
During the second quarter of 2025, the carnitine prices in the USA reached 24090 USD/MT in June. Demand from dietary supplements and pharmaceutical applications guided procurement activity. Buyers aligned purchases with production requirements, while supply availability supported routine sourcing.
During the second quarter of 2025, the carnitine prices in China reached 21410 USD/MT in June. Consumption from nutraceutical and export-focused supplement manufacturing influenced buying patterns. Producers operated according to scheduled output, and buyers sourced material based on confirmed orders.
During the second quarter of 2025, the carnitine prices in Germany reached 31215 USD/MT in June. Demand from pharmaceutical and clinical nutrition sectors shaped procurement volumes. Buyers emphasized compliance with quality and regulatory standards, influencing sourcing preferences.
During the second quarter of 2025, the carnitine prices in India reached 19960 USD/MT in June. Domestic supplement manufacturing activity supported demand. Buyers coordinated procurement with production planning, while import flows influenced availability.
During the second quarter of 2025, the carnitine prices in the United Kingdom reached 27045 USD/MT in June. Consumption from sports nutrition and medical nutrition segments influenced procurement. Buyers scheduled sourcing based on formulation requirements and supply planning.
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the carnitine prices.
Q3 2025:
As per the carnitine price index, Europe experienced upward price movement, reflected by increases in Germany and the United Kingdom. Demand from pharmaceutical manufacturing, clinical nutrition, and regulated dietary supplement production supported consumption across the region. Increased focus on therapeutic and preventive health applications drove usage in specialized formulations. Buyers emphasized supplier qualification, traceability, and compliance with regulatory standards. Procurement strategies were aligned with production planning for high-value formulations rather than volume expansion.
Q2 2025:
In Europe, carnitine demand was shaped by pharmaceutical production schedules and nutraceutical formulation planning. Buyers coordinated procurement with manufacturing timelines and regulatory approval requirements. Consumption patterns reflected steady usage in medical nutrition and supplement applications. Supply availability and established import channels supported sourcing, while procurement decisions prioritized quality consistency and certification standards.
This analysis can be extended to include detailed carnitine price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
Q3 2025:
As per the carnitine price index, North America experienced upward price movement, reflected by increases in the USA. Demand from sports nutrition, dietary supplements, and pharmaceutical applications strengthened consumption. Increased focus on active lifestyle products and clinical nutrition supported higher usage. Buyers secured material ahead of formulation cycles, while procurement emphasized supplier reliability and compliance with food and drug regulations.
Q2 2025:
In North America, carnitine demand reflected procurement aligned with supplement manufacturing and pharmaceutical production planning. Buyers focused on sourcing volumes matched to operational needs. Consumption was driven by routine production of nutraceutical products, while supply availability supported structured purchasing without encouraging excess inventory build-up.
Specific carnitine historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Q3 2025:
As per carnitine price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the carnitine pricing trends and carnitine price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on carnitine prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East and Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Q3 2025:
Asia Pacific experienced upward pricing momentum, reflected by increases in China and India. Expansion in nutraceutical manufacturing and export-oriented supplement production supported higher carnitine consumption. Demand from functional food and dietary supplement sectors influenced procurement volumes. Buyers coordinated sourcing with manufacturing schedules and regulatory compliance requirements.
Q2 2025:
In Asia Pacific, carnitine demand was driven by pharmaceutical and nutraceutical manufacturing activity. Buyers scheduled procurement based on production planning and export commitments. Supply availability supported sourcing across major producing and consuming countries, while procurement decisions emphasized quality assurance.
This carnitine price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Q3 2025:
Latin America's carnitine market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in carnitine prices.
Q2 2025:
Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting Latin America’s ability to meet international demand consistently. Moreover, the carnitine price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing carnitine pricing trends in this region.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
IMARC's latest publication, “Carnitine Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the carnitine market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of carnitine at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed carnitine prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting carnitine pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

The global carnitine industry size reached USD 327.2 Million in 2025. By 2034, IMARC Group expects the market to reach USD 585.4 Million, at a projected CAGR of 6.68% during 2026-2034. Market growth is supported by rising demand for dietary supplements, increasing use of carnitine in pharmaceutical and clinical nutrition applications, growing awareness of metabolic health, and expanding consumption of functional and sports nutrition products globally.
Latest News and Developments:
Carnitine a natural compound occurring in the body of a human being happens to be synthesized from amino acids namely, lysine and methionine. It is a part of energy metabolism that helps in the transportation of fatty acids into mitochondria by which they are oxidized, and further energy is obtained. Moreover, carnitine conducts the task of removing the improper products of metabolism from cells which consequently leads to better cellular health.
Commercially, carnitine is synthesized chemically or extracted from natural sources. Animal tissues, and particularly red meat, are the main sources of carnitine extraction. It can be either from natural sources or synthetic resources to satisfy industrial demand.
Carnitine supplements are very popular for many reasons, including increasing athletic performance, boosting fat burning leading to weight loss as well as relieving angina and peripheral artery. The multiple functions of carnitine such as its usage in the treatment of carnitine deficiency disorders and composition in infant formulas to mimic the nutritional composition of breast milk are also considered.
| Key Attributes | Details |
|---|---|
| Product Name | Carnitine |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Carnitine Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.